Skip to main navigation
Top
Skip to main content
Agios Logo Agios Logo
  • About Us

    About Us

    • Values
    • History
    • Leadership
    • Corporate Social Responsibility
    • Access to Medicines
    • News
      About Us
    • Values

    • History

    • Leadership

    • Corporate Social Responsibility

    • Access to Medicines

    • News

  • Rare Diseases

    Rare Defined Diseases

    • Pyruvate Kinase Deficiency
    • Thalassemia
    • Sickle Cell Disease
    • Our Science
      Rare Diseases
    • Pyruvate Kinase Deficiency

    • Thalassemia

    • Sickle Cell Disease

    • Our Science

  • Pipeline

    Pipeline

  • Our Medicines

    Our Medicines

  • Patients & Partners

    Patients & Partners

    • Patients & Caregivers
      • Clinical Trials

      • Patient Resources

    • Healthcare Providers

      • Healthcare Provider Resources

      • Clinical Data Sharing

    • Partner Opportunities

        Patients & Partners
      • Patients & Caregivers

        • Clinical Trials

        • Patient Resources

      • Healthcare Providers

        • Clinical Data Sharing

      • Partner Opportunities

      • Investors

        Investors

        • News & Events
        • Stock Information
        • Corporate Governance
        • Financials
        • IR Resources

          Investors

        • News & Events

        • Stock Information

        • Corporate Governance

        • Financials

        • IR Resources

      • Inside Agios

        Inside Agios

        • Careers

        • Culture

        • Diversity

        • Commitment to Community

        • Benefits

          Inside Agios
        • Careers

        • Culture

        • Diversity

        • Commitment to Community

        • Benefits

      Event Details

      • Investors Overview
      • News & Events
        • Press Releases
        • Publications
        • Events & Presentations
      • Stock Information
      • Corporate Governance
        • Leadership
        • Board of Directors
        • Environment, Social and Governance (ESG) Report
      • Financials
        • SEC Filings
        • Annual Reports & Proxy
        • Quarterly Results
      • IR Resources
        • Investor FAQs
        • IR Contact
        • Information Request
        • Email Alerts

      Q3 2018 Agios Pharmaceuticals Inc Earnings Conference Call

      Nov 01, 2018 at 8:00 AM EDT

      Click here for webcast

      Supporting Materials

      Third Quarter 2018 Financial Results Presentation 8.2 MB
      • latest-earnings-call Latest Earnings Call View Replay
      • latest-form-10-k Latest Form 10-K View PDF
      • email-alerts Email Alerts Sign Up
      • corporate-responsibility Corporate Responsibility View PDF

      Connect with us on LinkedIn or follow us on X.

      LinkedIn logo Connect on LinkedIn
      Twitter logoFollow us on X
      • Contact
      • About Us
      • Partner Opportunities
      • Careers
      Agios Logo

      Agios Pharmaceuticals, Inc. © 2026

      All right reserved.

      • Cookies Preferences
      • Copyright Info
      • Compliance
      • Sitemap
      • Privacy Notice
      • Terms of Use